TY  - JOUR

T1  - P153 An integrated analysis of zoledronic acid (ZA) for prevention of aromatase inhibitor associated bone loss (AIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (LET)

JO  - The Breast

PY  - 2007/03/01

AU  - Brufsky A

AU  - Bundred N

AU  - Coleman R

AU  - Lambert-Falls R

AU  - Mena R

AU  - Dong M

AU  - Schenk N

AU  - Lacerna L

AU  - Perez E

ED  - 

DO  - DOI: 10.1016/s0960-9776(07)70213-8

PB  - Elsevier BV

VL  - 16

SP  - S57

EP  - S57

Y2  - 2025/10/10

ER  -